Internal Medicine, Medical Oncology · Aurora, CO
NPI
1760431472
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
12605 E 16th Ave
Aurora, CO, 80045
Phone (720) 848-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
181 services
Medicare patients, 2024
88
Average age 72
Drug cost, 2024
$889K
263 prescriptions
Company payments, 2025
$1,650
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wells Messersmith was code 99215 (office e&m - established), 104 times for 53 patients. In total Wells Messersmith billed 181 services in 8 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 104 | 53 | $109.51 | $11K |
| 99215 Office E&M - Established | Office | 30 | 19 | $141.97 | $4,259 |
| 99205 Office E&M - New | Facility | 22 | 22 | $142.23 | $3,129 |
| 99214 Office E&M - Established | Facility | 13 | 13 | $76.24 | $991 |
By year: 2022 $43K for 360 services; 2023 $22K for 207 services; 2024 $21K for 181 services.
Medicare prescription drug claims, 2024
In 2024, the drug Wells Messersmith prescribed most often to Medicare patients was Ondansetron Hcl, with 20 prescriptions and refills. In total Wells Messersmith wrote 263 Medicare prescriptions that cost $889K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Hcl Generic | 20 | 20 | 11 | $180 |
| Fentanyl Generic | 20 | 20 | Under 11 | $3,798 |
| Fruzaqla Fruquintinib | 18 | 18 | Under 11 | $464K |
| Prochlorperazine Maleate Generic | 14 | 14 | Under 11 | $181 |
| Everolimus Generic | 13 | 13 | Under 11 | $3,586 |
| Mirtazapine Generic | 13 | 17 | Under 11 | $63.28 |
| Eliquis Apixaban | 12 | 36 | Under 11 | $21K |
| Welireg Belzutifan | 11 | 11 | Under 11 | $96K |
Brand drugs: - claims; generic drugs: 182 claims; opioid claims: 38.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wells Messersmith $1,650 (- in general payments such as food, travel and fees and $1,650 for research) from 3 companies. The largest payer was Amgen Inc. with $1,650.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 2 | $1,650 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.